Correction to Lancet Respir Med 2022; 10: 650-60

No authors listed

Published Erratum

No authors listed. Lancet Respir Med. 2022 Jul.

. 2022 Jul;10(7):e72.

doi: 10.1016/S2213-2600(22)00128-X. Epub 2022 Apr 5.

No abstract available

Erratum for

Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study.
Wechsler ME, Menzies-Gow A, Brightling CE, Kuna P, Korn S, Welte T, Griffiths JM, Sałapa K, Hellqvist Å, Almqvist G, Lal H, Kaur P, Skärby T, Colice G; SOURCE study group. Wechsler ME, et al. Lancet Respir Med. 2022 Jul;10(7):650-660. doi: 10.1016/S2213-2600(21)00537-3. Epub 2022 Mar 29. Lancet Respir Med. 2022. PMID: 35364018 Clinical Trial.